Literature DB >> 14645229

Regulation of collagenase activities of human cathepsins by glycosaminoglycans.

Zhenqiang Li1, Yoshiyuki Yasuda, Weijie Li, Matthew Bogyo, Norman Katz, Ronald E Gordon, Gregg B Fields, Dieter Brömme.   

Abstract

Cathepsin K, a lysosomal papain-like cysteine protease, forms collagenolytically highly active complexes with chondroitin sulfate and represents the most potent mammalian collagenase. Here we demonstrate that complex formation with glycosaminoglycans (GAGs) is unique for cathepsin K among human papain-like cysteine proteases and that different GAGs compete for the binding to cathepsin K. GAGs predominantly expressed in bone and cartilage, such as chondroitin and keratan sulfates, enhance the collagenolytic activity of cathepsin K, whereas dermatan, heparan sulfate, and heparin selectively inhibit this activity. Moreover, GAGs potently inhibit the collagenase activity of other cysteine proteases such as cathepsins L and S at 37 degrees C. Along this line MMP1-generated collagen fragments in the presence of GAGs are stable against further degradation at 28 degrees C by all cathepsins but cathepsin K, whereas thermal destabilization at 37 degrees C renders the fragments accessible to all cathepsins. These results suggest a novel mechanism for the regulation of matrix protein degradation by GAGs. It further implies that cathepsin K represents the only lysosomal collagenolytic activity under physiologically relevant conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645229     DOI: 10.1074/jbc.M310349200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.

Authors:  Guilherme Baldo; Susan Wu; Ruth A Howe; Meera Ramamoothy; Russell H Knutsen; Jiali Fang; Robert P Mecham; Yuli Liu; Xiaobo Wu; John P Atkinson; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2011-08-24       Impact factor: 4.797

2.  Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.

Authors:  Urska Repnik; Amanda E Starr; Christopher M Overall; Boris Turk
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

3.  A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis.

Authors:  Hyejin Lee; Christopher M Overall; Christopher A McCulloch; Jaro Sodek
Journal:  Mol Biol Cell       Date:  2006-09-13       Impact factor: 4.138

4.  Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3.

Authors:  Xian Wu Cheng; Masafumi Kuzuya; Kae Nakamura; Qun Di; Zexuan Liu; Takeshi Sasaki; Shigeru Kanda; Hai Jin; Guo-Ping Shi; Toyoaki Murohara; Mitsuhiro Yokota; Akihisa Iguchi
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

5.  Chondroitin sulfate promotes activation of cathepsin K.

Authors:  Peter A Lemaire; Lingyi Huang; Ya Zhuo; Jun Lu; Carolyn Bahnck; Shawn J Stachel; Steve S Carroll; Le T Duong
Journal:  J Biol Chem       Date:  2014-06-23       Impact factor: 5.157

6.  Potential role of cathepsin K in the pathophysiology of mucopolysaccharidoses.

Authors:  Susan Wilson; Dieter Brömme
Journal:  J Pediatr Rehabil Med       Date:  2010

Review 7.  Cysteinyl cathepsins in cardiovascular diseases.

Authors:  Xian Zhang; Songyuan Luo; Minjie Wang; Guo-Ping Shi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-01-09       Impact factor: 3.036

Review 8.  Optimizing dentin bond durability: control of collagen degradation by matrix metalloproteinases and cysteine cathepsins.

Authors:  Leo Tjäderhane; Fabio D Nascimento; Lorenzo Breschi; Annalisa Mazzoni; Ivarne L S Tersariol; Saulo Geraldeli; Arzu Tezvergil-Mutluay; Marcela R Carrilho; Ricardo M Carvalho; Franklin R Tay; David H Pashley
Journal:  Dent Mater       Date:  2012-08-16       Impact factor: 5.304

9.  Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities.

Authors:  Susan Wilson; Saadat Hashamiyan; Lorne Clarke; Paul Saftig; John Mort; Valeria M Dejica; Dieter Brömme
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

10.  Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI.

Authors:  Alessandra Tessitore; Marinella Pirozzi; Alberto Auricchio
Journal:  Pathogenetics       Date:  2009-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.